This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: implantable defibrillators

July 2020 Br J Cardiol 2020;27:93–6 doi:10.5837/bjc.2020.023

Shared decision-making for ICDs: a regional collaborative initiative

Honey Thomas, Mark Lambert, Chris Plummer, Craig Runnett, Richard Thomson, Anne Marie Troy-Smith, Andrew J Turley

Abstract

Introduction Most clinicians support the idea of person-centred care as a model of best practice, yet we know from published research and National Health Service (NHS) patient surveys that people still want to be more involved in decisions about their healthcare.1,2 In shared decision-making (SDM), healthcare professionals and individuals work together to select tests, treatments, management or support packages based on evidence and the individual’s informed preferences.3 This evidence should be the best available assessment of the likely benefits, risks, and outcomes of the options, with the individual’s values and preferences being cent

| Full text
Pacing supplement: Introduction

October 2018

Pacing supplement: Introduction

Paul Foley

Abstract

Pacing practice has moved on from the start with unipolar pacing and now practice includes implantable defibrillators and cardiac resynchronisation therapy (CRT) for the treatment of heart failure, with parallel developments in remote follow up. Direct His Bundle pacing is now feasible using specially designed guide catheters and a standard pacing lead and appears to have significant benefits with reductions in heart failure hospitalisation, atrial fibrillation and mortality. The supplement also looks at progress in pacemaker and defibrillator lead extraction, as well as the fast evolving field of leadless pacing. We are pleased to provide

| Full text

August 2013 Br J Cardiol 2013;20:92-93 Online First

News from EHRA: biomarkers may help stratify sudden cardiac death risk

News from the world of cardiology

Abstract

Details of two biomarker discovery programmes were presented by myself and other colleagues from Southampton.The early results were generated by our team, headed by Professor John Morgan, and build on several years of collaboration between cardiologists at the University Hospitals Southampton and scientists at the University of Southampton. The work hopes to advance sudden cardiac death risk stratification and ultimately move towards a more personal selection of interventions, such as implantable defibrillators. Traditional risk stratification markers, such as left ventricular function or QRS width, fail to identify those at greatest risk, or

| Full text
Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now